European Commission approves Ponvory a once daily, oral therapy for the treatment of relapsing forms of multiple sclerosis – Janssen
Janssen, the Pharmaceutical Companies of Johnson & Johnson, announced that the European Commission (EC) has approved Ponvory (ponesimod) for the treatment of adult patients with relapsing multiple sclerosis… read more.